Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology

NCT01660776 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT01660776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01660776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Completed
Start date
June 7, 2012
Completion date
October 2, 2019
Enrollment
105 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma, hodgkin lymphoma, metastatic breastcancer, non-small cell lung cancer